# A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension

> **NCT01484431** · PHASE1,PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Tadalafil- Tablet or Oral suspension

## Key facts

- **NCT ID:** NCT01484431
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-17
- **Primary completion:** 2017-04-21
- **Final completion:** 2019-04-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01484431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01484431, "A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01484431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*